DataCloudKnowledgetrainingcoordination

L1000 LINCS DCIC FIBR037 MCLF035SZ 6H H09 inhibitor-BEC 4uM.tsv.gz (File)

Taxon:

Homo sapiens

Taxon (Entity type)

Subject:

MCLF035SZ

Subject (Entity type)

Project:

LINCS-2021

Project (Entity type)

File Format:

TSV

File Format (Entity type)

Dcc Asset:

datapackage.zip

Processed File (Entity type)

Dcc:

LINCS

DCC (Entity type)

Data Type:

gene expression profile

Data Type (Entity type)

Compression Format:

GZIP format

File Format (Entity type)

Biosample:

L1000 LINCS DCIC 2021 FIBR037 MCLF035SZ 6H H09 inhibitor-BEC 4uM

Biosample (Entity type)

Assay Type:

landmark transcript profiling assay

Assay Type (Entity type)

Uncompressed Size In Bytes:191 KB

Size In Bytes:89.6 KB

Sha256:8a00c9039f32514f624e0e9d18c8a2ad9fc8e6e31d1650f959eba591dcac3e4b

Persistent Id:drs://drs.lincs-dcic.org/edcdb37fc05ebbd3590b3b6f5a75c89d

Mime Type:application/gzip

Md5:edcdb37fc05ebbd3590b3b6f5a75c89d

Filename:L1000_LINCS_DCIC_FIBR037_MCLF035SZ_6H_H09_inhibitor-BEC_4uM.tsv.gz

Creation Time:2021-01-21T00:00:00

Access Url:

drs://drs.lincs-dcic.org/edcdb37fc05ebbd3590b3b6f5a75c89d

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC 2021 FIBR037 MCLF035SZ 6H H09 inhibitor-BEC 4uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 FIBR037 MCLF035SZ 6H H09 inhibitor-BEC 4uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.